Defra has announced that Great Britain is to be declared bluetongue-free from 5th July 2011.
From this date, bluetongue susceptible species being exported from Great Britain will no longer need to be vaccinated against BTV8 or meet any of the other 'Annex III conditions.
However, the current EU Bluetongue Directive only allows bluetongue vaccination within a protection zone, so from 5th July vaccination will no longer be permitted in Great Britain.
The British Veterinary Association is supporting Defra to lobby for these rules to be changed to allow vaccination in bluetongue areas.
Harvey Locke, BVA President, said: "The move to bluetongue freedom is thanks to the excellent partnership between government, farmers and vets across Great Britain. It is a tremendous achievement to turn the situation around from the outbreak in 2007 to freedom in 2011.
"We are disappointed that changes to the EU Directive to allow vaccination to continue could not be made before the deadline and we will continue to work with Defra to try to secure this change as soon as possible to allow vets and farmers to make the right choice to protect their herds.
"Those farmers and vets that wish to vaccinate must do so before the 5th July.
"The BVA would reiterate the message to farmers to source stock responsibly to help avoid a future outbreak."
The review coincided with a move last month from RUMA, the agricultural and food industry alliance which promotes responsible use of medicines in farm animals, to align with the EMA position.
The announcement means that under PVS guidelines, fluoroquinolones, 3rd and 4th generation cephalosporins and colistin will retain Class 3 status. This means they are only used when no other options are available and when supported by laboratory sensitivity testing – or exceptionally when all other options have failed.
Class 1 antibiotics form the standard prescribing list within responsible use guidelines and Class 2 are used only when sensitivity tests or clinical experience proves standard antibiotics are not effective. In all treatment decisions the health and welfare of the pigs must always take priority.
Betalactams with betalactamase inhibitors (clavulanic acid) were previously in the highest priority Class 3 but in light of the list defined by the EMA, which has been adopted by the Veterinary Medicines Directorate as well as RUMA, the PVS has reassessed the risk and moved them to Class 2 to align them with plain betalactams. This means they are still subject to voluntary restrictions, but their use would not necessarily be only as a last resort.
PVS president Mark White said that despite the ongoing review process and the potential to reclassify certain products, the Society’s underlying principles remain unchanged: "The total amount of all antibiotics used on pig farms to treat and prevent disease should be minimised, and the types of antibiotics used in pigs should be considered in light of the implications for antibiotic resistance challenges in both pigs and man.
"This policy is proving successful with AHDB Pork’s electronic pig medicine book (e-MB) recently showing that use of colistin appears to have fallen by over 70% in 2016 following its move to a Class 3 antibiotic in late 2015.
"We must also continue to be alert to the possibility of cross resistance, even in older antibiotics that have little or no use in humans. Risk must be acknowledged where it exists and overall reductions are still imperative."
RUMA has welcomed the review and alignment from the PVS. Secretary General John FitzGerald said: "Farmers and vets need boundaries within which to operate and clear objectives to meet, and we would urge all supply chains, from farmer to retailer, to align with the sector position on best practice use of antibiotics, as defined by each sector’s professional veterinary organisation."
Forum Animal Health is launching a new programme designed for transition cows to help avoid milk fever relapses: the Milk Fever Pack.
According to the company, the new Milk Fever Pack provides a continuous and complete supply of readily available oral calcium to avoid relapses which also gives the cow extra support until her system is back in control. Unlike intravenous calcium, oral calcium will not suppress parathyroid hormone (PTH) release and therefore will not turn off the cow's natural mechanism to regulate blood calcium levels.
Each pack contains one sachet of Agger's® Fresh Cow which supplies essential calcium, energy and rehydrates the cow; and two tubes of Botonic® Calcium which create a mild metabolic acidosis to enable the cow to mobilise calcium efficiently.
Forum Animal Health says the new Milk Fever Pack has been developed in close collaboration with a leading veterinary nutritionist to allow veterinary surgeons to be involved at an earlier stage. The veterinary surgeon can then leave a follow-up protocol for the client to use, helping to avoid milk fever relapses. It gives veterinary surgeons a chance to introduce standard operating procedures into herd health plans bringing better control of milk fever on farms.
For more information, please contact Forum Animal Health on 01737 781416 or animal.health@forumgroup.co.uk.
The World Veterinary Poultry Association (WVPA) has announced that nominations are now open for its Young Poultry Veterinarian of the Year 2015 Award, sponsored by Zoetis.
The award, now in its fourth year, is open to qualified poultry veterinarians who are under the age of 35 on January 1, 2015. The winner will be selected by a global panel of judges and will receive a USD$5,000 contribution towards attending international scientific or continued professional development meetings.
The WVPA is calling for nominations to be made on behalf of young veterinarians who have excellent poultry diagnostic and advisory skills, are effective communicators and transferors of their knowledge and can demonstrate a real passion for their industry.
Nigel Horrox, vice president of the WVPA said: "We continue to be impressed by the calibre of entries for this award, and we are confident that this year will be no exception.
"We are looking for an individual who is not only invaluable to their local poultry industry, but who consistently goes above and beyond the call of duty and is a credit to their profession."
Hector Badillo, group director of global marketing at Zoetis, said the contribution made by young poultry veterinarians is vital to the future of the industry. "We are proud to support this award, which recognises top new talent in the global poultry industry and the outstanding contribution made by an individual."
Entries for the award are to be made via the dedicated website: www.wvpa-award.com. Nominees/applicants are asked to describe in 500 words or less their role and achievements in the industry and why they feel they should win the award. The award will be presented at the XIX Congress of the World Veterinary Poultry Association, Cape Town, South Africa, September 7-11, 2015.
Closing date for entries is March 31, 2015.
Anyone unable to attend the latest in the increasingly popular BVA Animal Welfare Foundation discussion forums, held in May, can now catch up on the presentations on VETS.TV - the new web TV service currently being piloted by BVA - which can be accessed at www.vets.tv.
All the presentations, including ‘Put your money where your mouth is - can people afford animal welfare in food production', ‘Designer animals or breeding for welfare' and ‘Electric aid or shock collar' as well as the Norman Hayward Fund sponsored session - which included presentations on both the British Equine Veterinary Association (BEVA) and Edinburgh University laminitis studies and the casualty slaughter of sheep - along with the Chair of the BVA:AWF Trustees, Carl Padgett's summary of the day, are now available online to view at your convenience.
Also new on VETS.TV is an interview with Young Vet Network (YVN) senior graduate BVA Council representative, Louisa Rance who talks about the work of the YVN and how it is helping newly qualified vets with the challenges faced after leaving vet school and a series of videos, courtesy of Farmers Weekly, on Bluetongue - what it is, how it is transmitted, the symptoms and vaccination advice.
Pfizer has sponsored the publication of a new English-Polish dairy health guide for vets to give farmers.
The guide has been published to help farm staff from Poland improves their knowledge, skills and performance at work. Topics covered including milking routines, causes and control of clinical mastitis, intramammary tube infusion and dry cow therapy.
Copies are available free of charge from Pfizer Animal Health's Dairy Territory Managers, or by calling 01737 330727.
A survey of more than 3,000 farms has found that 16% employed foreign workers, among whom more than half were from Poland.1 According to Pfizer's livestock business director Tomas Rosival, Polish workers are keen on training and eager to put it into practice and get results.
He said: "Communication is the key. By presenting each topic in English and Polish on facing pages, the booklet helps develop workplace vocabulary and language skills as well as improving technical knowledge."
[1] Farm Business, 2009. The significance of migrant labour in UK agricultural employment. Survey of 3,375 farms.
A new long acting sheep injection has been launched by Fort Dodge Animal Health which the company says will offer significant benefits to sheep farmers for both internal and external parasite control.
Cydectin 2% LA for sheep is the latest product to join the Cydectin range and follows the long acting injection for cattle.
Based on Moxidectin, the product delivers a long action against worms, up to 111 days and scab, 60 days from a single injection.
Andrew Wylie from Fort Dodge said: "To put this into context, apart from the existing Cydectin range which lasts up to 35 days, no other product is licensed with persistent activity against worms and scab. Cydectin 2% LA for sheep offers three times the worm cover and double the scab cover from a single injection.
"Therefore farmers will benefit from Cydectin 2% LA through the combination of a single injection with extended persistency leading to a reduction in the number of treatments needed for worms and scab and the potential increase in lamb weight gain due to a lower worm and scab challenge."
Fort Dodge recommends the following three key uses for Cydectin 2% LA given the persistent effect and single shot:
Administration is by a single sub-cutaneous injection high up the neck at the base of the ear which is designed to limit the withhold period to 104 days. The technique is not difficult and, if used with the multidose applicator supplied, farmers will find it a straightforward procedure.
Cydectin 2% LA is available in 50ml, 200ml and 500ml bottles and with a dose rate of 1ml per 20kg, a 500ml pack will treat 200 sheep at 50kg. For further, call Fort Dodge on 01489 781711.
The new gel is made from natural resin combined with zinc salts which NoBACZ says provides both physical and microbial protection.
NoBACZ says that unlike water-based gels and sprays, including aerosols, that dilute in water and wash away, Ambugreen’s natural resin is hydrophobic which improves contact times between the product and the skin in wet conditions.
The gel barrier can be used anywhere on the skin where a bandage or spray has conventionally been used for protection, such as the management of lameness and to protect sore skin in livestock and to manage udder cleft issues in cows.
Ambugreen also offers fly protection and is suitable for use on all livestock, including copper-sensitive sheep breeds.
Dr David Charles, veterinary surgeon and international business development manager at NoBACZ Healthcare, said: “Ambugreen provides farmers with next generation protection for their livestock and is the perfect antibiotic-free tool to help protect wounds from bacterial ingress from the environment; enhancing the health and welfare of animals whilst preventing economic losses.”
Laura Donovan, veterinary surgeon and partner at Nantwich Farm Vets, adds: “We were lucky enough to have trialled Ambugreen with our dairy clients who have successfully used the gel barrier for udder cleft dermatitis and were very pleased with the results.”
www.nobacz.com
Defra's Chief Veterinary Officer's annual report was published this week, reviewing developments in animal health and welfare during 2007.
The report, by former Chief Veterinary Officer (CVO) Fred Landeg, summarises progress and developments in the field of animal health and welfare within Great Britain. It also provides a continuous statistical record of the state of animal disease in Great Britain.
Topics covered in the 2007 report include the outbreaks of Foot and Mouth Disease, Avian Flu and Bluetongue, and progress on the UK's Responsibility and Cost Sharing Programme.
Other major areas covered in the report are:
A copy of the full report can be found at http://defraweb/animalh/cvo/report.htm
Norbrook has launched an Android version of its existing free iPhone app: ‘the Veterinary Excellence Tool’ (VET).
VET offers a range of functions to assist veterinary professionals and farmers including a product dosing calculator. The Android version has been developed to meet customer demand and has the same features as the Apple version which is available for both iPhones and iPads.
Norbrook highlights the following features of the app:
The app can be downloaded for free by searching for “Norbrook” in either app store.
For further information please contact Laura Holmes, E-Marketing Manager, laura.holmes@norbrook.co.uk or 01536 741147.
Janssen Animal Health has launched a new website providing information on the subject of coccidiosis in calves and lambs: www.takingcareofcoccidiosis.com.
The website builds on the findings of an expert workshop on bovine coccidiosis held at the First European Buiatrics Conference, which was facilitated by Janssen. In particular, the site looks at all of the areas that the experts focused on as being especially problematic, including immunity, sources of infection, risk factors, prevention and treatment.
According to the company, arriving at a diagnosis of coccidiosis is not always straightforward: it must be supported by history and clinical signs, as well as evidence of pathogenic species of the Eimeria parasite. Interpretation of oocyte counts can be particularly difficult and results have to be viewed in the context of the farm situation. The site contains explanations about the timing of sampling and how that can impact upon the results.
Janssen adds that treatment has traditionally relied on fluid therapy and the use of sulphonamide drugs but recommendations on the use of more recently introduced treatments such as diclazuril (Vecoxan) focus on single dose treatments administered 14 days after a stress factor - such as moving to a higher risk environment, weaning or transportation. The various treatment strategies including prophylactic and metaphylactic approaches are described for those who have experienced problems with coccidiosis in the past and want to avoid recurrence on an individual farm.
Janssen says the site is an ideal on-line resource for veterinary professionals, SQPs and farmers looking to update their knowledge, seeking a tool that explains the disease in greater depth or just searching for specific information that helps in their own individual situation or with interpretation of a difficult case, www.takingcareofcoccidiosis.com/.
Vetoquinol is offering vets the opportunity to win one of five Selekt Cattle Pumps worth £240. In order to take part, you'll need to tell Vetoquinol about your experiences with Marbocyl 10% when treating acute mastitis.
Susan Mitchell, Vetoquinol's Large Animal Product Manager said: "This case study competition aims to gather information on the incidence and treatment of acute mastitis. Acute mastitis is a genuine veterinary emergency and rapid treatment is vitally important."
Vetoquinol says Marbocyl 10% has proven to be an effective treatment for acute E.coli mastitis, with a bactericidal action which does not liberate endotoxins. Administered intravenously, Marboyl 10% provides rapid improvement and an early return to milk production.
The company also says farmers have found toxaemic mastitis cases have benefited from the use of fluid therapy, using the Selekt Cattle Pump. Oral fluid therapy is a quick, easy and inexpensive option to intravenous treatment and improves the efficacy of hypertonic saline.
To enter the competition, visit http://www.vetoquinol.co.uk/, click the Marbocyl link on the right, and download and complete a brief case history.
Five winners will be chosen at random on 30th June 2010.
The industry-led Cattle Health and Welfare Group of Great Britain (CHAWG) has published a review which identifies a practical approach to gathering antibiotic usage data on UK cattle farms.
The review outcomes, announced today at a joint conference held by the Responsible Use of Medicines in Agriculture Alliance (RUMA) and the Veterinary Medicines Directorate (VMD), highlight the significant benefits better data could deliver, such as improving the way antibiotics are administered strategically to tackle disease.
But CHAWG’s chair Tim Brigstocke says it’s also important that the industry is able to accurately report usage levels because of the rising levels of antibiotic-resistant bacteria which threaten human health.
"We found that while data is already stored at every vet practice and in every farm medicine book, it currently exists in many different forms. It’s also not collected or collated, and is further complicated by multi-species approvals for many of the antibiotics.
"This means we can’t always be sure in which type of animal a medicine has been used. For example, out of 420 tonnes of animal-authorised antibiotic active substance sold in the UK in 2013, only 14 tonnes was authorised solely for use in cattle. However, 63 tonnes was authorised for multi-species use in food producing animals and within the 217 products included in this, 201 are authorised for use in cattle."
Tim says that with the support of the VMD, which requested the review and will now act as secretariat, CHAWG will set up a working group to implement the report’s recommendations.
The starting point is likely to be the survey of vets carried out by the British Cattle Veterinary Association (BCVA), which formed part of the review. This suggested vets could be using as many as 15 different software programmes to log data, so CHAWG will be working with the BCVA and individual practices to look at how standard sets of data can be anonymised and exported.
"Then we will almost certainly look at how cattle farmers can be supported in migrating records from the physical ‘medicine book’ on the farm, into a spreadsheet or existing cattle management software for anonymous aggregation on a national level.
"There are undoubtedly areas where we can improve the effectiveness of how we use these powerful medicines to improve welfare. But the antibiotic resistance debate is an emotive one and we must also demonstrate accountability to ensure the preservation of antibiotics for future use in humans and animals; any future curbs on usage should be proportionate and informed, and not compromise animal wellbeing."
Mandatory reporting in Europe could be just over the horizon and the European Medicines Agency has focused in the past year on developing a method for data collection on the usage of antibiotics in the EU pig sector. In the UK, the VMD is encouraging the livestock sectors to develop systems appropriate to their own unique circumstances and industry characteristics.
Tim said: "It’s therefore in cattle farmers’ own interests to anticipate the kind of figures it might be asked to supply in the future, and develop a way of collecting that data which suits the way the UK industry works.
"Then we can retain control over the data and the methodology, and ensure the reporting is accurate – and this in turn will help the VMD represent our case better in Europe as this debate continues.
CHAWG says that throughout this project, it will be liaising with others – such as the pig sector – to ensure learnings are shared, duplication avoided and efficiencies realised where possible.
The CHAWG review report is available to download at www.chawg.org.uk.
Novartis Animal Health has announced that it is offering regular updates Schmallenberg virus, including the number and counties of affected farms, on its farm animal health website: www.farmanimalhealth.co.uk.
The new website is a resource for vets, SQPs and farmers and also contains background information on the virus, its symptoms and suggestions for control.
Helen Langham, Brand Manager at Novartis Animal Health, said: "There is still a lot that isn't known about the Schmallenberg virus, so it is essential that those involved in the animal health industry and livestock production are kept informed. Our website provides current information and links to relevant resources to help people stay up to date".
For more information go to www.farmanimalhealth.co.uk/latestdiseaseupdates
Intervet/Schering-Plough has announced that Estrumate®, in both the 10ml and 20ml vial size is back in stock and available to order from your veterinary wholesaler.
The stock out situation had arisen as a result of increased demand during the early part of the year but the company is confident that there will be sufficient stock to supply the increased level of demand in the foreseeable future. Intervet/Schering-Plough would like to thank their clients for the patience and understanding.
Further information is available from Intervet/Schering-Plough Account Managers or the Veterinary Support Group (VSG) on 01908 685685.
Defra has announced the detection of Bluetongue (Serotype 1) (BTV1) in five imported cattle on a premises near Blackpool in Lancashire.
The animals originated from within the BTV1 and 8 Restricted Zone in the south west of France and were detected as a result of post-import testing carried out by Defra on all Bluetongue susceptible animals arriving from continental Europe. The animals' documentation complied with the EU Bluetongue rules governing the movement of livestock as the movement occurred at least 60 days after they had been vaccinated.
This is the first case of BTV1 infection in the UK and the five animals have been culled as they may pose a disease threat to other animals. One further animal from the same consignment has also been culled. Test results for that animal were positive for bluetongue although it was not possible to determine the serotype.
There is no evidence that BTV1 is circulating in the UK and no additional control zones have been declared.
This response is in accordance with Defra's Bluetongue Control Strategy. The premises are now under restriction while an epidemiological investigation takes place. This will include further checks on the other animals present on the premises.
Chief Veterinary Officer Nigel Gibbens said: "This is the first case of BTV1 infected animals being imported into the UK. Taking into account the epidemiological evidence and the consideration of the risk represented to British livestock, I have taken the decision to cull these animals.
"This incident shows how important it is for farmers to consider potential disease risks when buying stock. Buyers need to consider how best to protect their own businesses and those of their neighbours and make sure they are clear about the stock they are intending to buy."
Defra continues to test all susceptible animals imported to the UK from continental Europe for all strains of Bluetongue and continues to urge industry to consider the risks and check the health and vaccination status of animals when sourcing any animals from within the UK or abroad.
In line with EU legislation, and our UK Control Strategy agreed with industry, control measures are in place in UK and abroad to prevent the spread of Bluetongue from existing zones around Europe:
Merial Animal Health has announced the first delivery of its bluetongue vaccine, BTVPURTM AlSap, in the UK. The shipment of just over 2 million doses is the first of several batches scheduled over the summer months and forms part of Merial's commitment to Defra to supply 13 million doses for England and Wales. Despite bluetongue disease not yet re-emerging in the UK this year, Merial strongly encourages farmers to protect their livestock from this potentially debilitating disease. Head of Production Animal Business, Graham Davenport said: "Our experience in continental Europe over the past four years has shown just how imperative vaccination is for vets and farmers in controlling this disease in the field. Recent outbreaks in France are a reminder that there is no room for complacency. Over the past few weeks we have been working closely with the members of JAB (Joint Action against Bluetongue) and strongly advocate that farmers should act on their advice: Don't hesitate, vaccinate."Information for veterinary professionals and livestock owners on BTVPUR AlSap can be found at www.merial.co.uk. Veterinary surgeons can also obtain information by calling 0800 592699 or emailing ukbluetongue@merial.com.
Virbac has announced that its recently launched parasiticide Neoprinil has been granted a shelf life extension from one to two years after first opening.
The company says the extension will help minimise the risk of wasted product and increase its convenience to farmers.
An eprinomectin pour-on solution, Neoprinil is indicated for use against internal and external parasites in cattle, including gut and lungworms, mange mites, sucking and chewing lice, horn flies and warbles. It is administered using the company's Farmpack and Flexibag, and offers a zero-day withdrawal period in milk.
Virbac's Product Manager for Large Animals Brigitte Goasduf MRCVS said: "Understanding the challenges our customers face and offering products to overcome them is our goal so we are delighted that Neoprinil has received a shelf life extension because this adds to its flexibility and convenience for farmers. It also brings it into line with Deltanil, our deltamethrin-based pour-on for use against a range of ectoparasites in cattle and sheep.
"We now offer a comprehensive and flexible parasiticide range administered with a dispensing system that sets a new standard for convenience and ease of use."
Neoprinil is presented in 2.5l, 4.5l and 8l pack sizes.
New research published in Epidemiology and Infection (Cambridge University Press) reveals that direct contact between badgers and cattle is rare, suggesting that it may be rare for bovine tuberculosis (TB) to be passed on through the two species meeting each other on pasture.
For the research, which was conducted by the Royal Veterinary College and the Food and Environment Research Agency, researchers investigated direct and indirect interactions between badgers and cattle by fitting automated high-tech proximity loggers to animals and placing base stations at badger latrines located on pasture, in an area of south-west England with a high-density badger population, over a period of 12-months.
Direct interactions (within 1.4 metres) between badgers and cows at pasture were very rare, with only four out of over 500,000 animal-to-animal contacts recorded between the two species.
Indirect interactions (visits to badger latrines) were far more frequent than direct contacts, with 400 visits by badgers and 1700 visits by cattle recorded. This suggests that indirect contacts might be more important than direct in terms of disease transmission at pasture.
During the study half of the badgers tested positive for TB, however the infection status of individual badgers did not affect the frequency or duration of their visits to latrines located on pasture grazed by cattle.
Bovine tuberculosis caused by infection with Mycobacterium bovis is endemic in cattle in parts of England and Wales and its control is hindered by the presence of infection in the European badger. While M. bovis is clearly transmitted between cattle and badgers, it is has not previously been known where, when or how often transmission occurs.
Dr Julian Drewe from the Royal Veterinary College who led the study, said: "Our findings reveal that direct contacts between badgers and cattle at pasture are surprisingly rare, despite ample opportunity for interactions to occur, suggesting that the two species may be ignoring or even actively avoiding one another. The study was conducted in an area with a high badger population, so it is likely that such direct contact will be even less frequent in areas of the country where there are fewer badgers.
"Indirect visits by both species to badger latrines were significantly more common than direct contacts between badgers and cattle, which suggests that these represent the more typical nature of interspecies contact. Future research aiming to quantify TB risk to cattle from badgers might be best to focus on indirect contacts occurring at latrines and on contacts occurring away from pasture, for example in farm buildings.
"This clearly has disease management implications, and more work is now needed in this area to look at how such contact can be limited, to reduce the number of cases of bovine TB in the future."
Led by Navaratnam Partheeban (Theeb) (pictured) OBE, Regional Head of Farm at IVC Evidensia, the programme is based on a methodology developed in the Netherlands.
The training focuses on the main behavioural indicators in cattle, helping vets and farmers assess health and welfare using basic senses such as looking, smelling, and feeling.
The one-day course includes a morning theory session followed by an on-farm practical session, equipping participants with skills to spot early signs of health or welfare issues before they become serious.
Theeb said: "Our goal is to train all our farm vets and vet techs in this approach, so they can provide even greater support to farmers.
"By integrating cow signals into routine practice, we can help farmers improve herd welfare, increase productivity, and contribute to more sustainable farming.
"Healthier cows live longer, produce more milk, and require less medical intervention.”
Petra Grabnar Rogers, Farm Veterinary Surgeon at Delaware Vets, an IVC Farm practice in Somerset, said: "The cow signals training has made a noticeable difference for our farmers.
"Being able to spot early signs of distress or health issues before they become bigger problems will help our farmers reduce vet visits and improve overall herd health.
"It's a simple yet effective approach that we hope will have a positive impact on the productivity of our farm clients."
IVC says that whilst this methodology is known in the UK, opportunities to receive formal training have traditionally been limited and it is the first corporate group to provide widespread cow signals training to all its farm vets.
The British Pig Executive (BPEX) is urging veterinary surgeons to promote a 'top five' of farm services which will be available to pig farmers that sign up to BPEX's new national pig health scheme.
The Pig Health Improvement Project (PHIP) became a national scheme in July following regional projects in Yorkshire, Humberside, East Anglia and the East Midlands. BPEX says it is now stepping up a gear as much of the infrastructure has been put in place and clear membership benefits are available.
BPEX's Vet Project Manager Helen Clarke said: "The PHIP takes a collaborative, action-orientated approach to reducing the incidence of disease in pig herds to ensure the long-term sustainability of pig farming. The role of vets in delivering the scheme is key.
"We need to achieve a high level of uptake - and are looking to achieve sign-up from farms that together represent at least 90% of sows nationally. And that's why we are keen for farmers to take advantage of these five services that deliver benefits at farm level."
The services consist of:
Sign-up is free for producers. To find out how vets can support the scheme, visit http://www.pighealth.org.uk/ and contact BPEX on 02476 478877.